Clinical and Experimental Pharmacology Physiology 27520523 2000 PMID 10874510 C

Clinical and experimental pharmacology physiology

This preview shows page 10 - 11 out of 12 pages.

Clinical and Experimental Pharmacology & Physiology 27:520–523, 2000. PMID: 10874510 C ICHEWICZ , D.L. Synergistic interactions between cannabinoid and opioid analgesics. Life Sciences 74:1317–1324, 2004. PMID: 14706563 C ORCHERO , J.; F UENTES , J.A.; AND M ANZANARES , J. Delta-9-tetrahydrocannabinol increases proopi­ omelanocortin gene expression in the arcuate nucleus of the rat hypothalamus. European Journal of Pharmacology 323:193–195, 1997 a . PMID: 9128838 C ORCHERO , J.; A VILA , M.A.; F UENTES , J.A.; AND M ANZANARES , J. Delta-9-tetrahydrocannabinol increases prodynorphin and proenkephalin gene expression in the spinal cord of the rat. Life Sciences 61:PL39–PL43, 1997 b . PMID: 9244374 C ORCHERO , J.; O LIVA , J.M.; G ARCIA -L ECUMBERRI , C.; ET AL . Repeated administration with delta9­ tetrahydrocannabinol regulates mu-opioid receptor density in the rat brain. Journal of Psychopharmacology 18:54–58, 2004. PMID: 15107185 C RISWELL , H.E., AND B REESE , G.R. A conceptual­ ization of integrated actions of ethanol contributing to its GABAmimetic profile: A commentary. Neuropsychopharmacology 30:1407–1425, 2005. PMID: 15856077 D I F RANZA , J.R., AND W ELLMAN , R.J. Sensitization to nicotine: How the animal literature might inform future human research. Nicotine & Tobacco Research 9:9–20, 2007. PMID: 17365732 F ATTORE , L.; C OSSU , G.; S PANO , M.S.; ET AL . Cannabinoids and reward: Interactions with the opioid system. Critical Reviews in Neurobiology 16:147–158, 2004. PMID: 15581410 F ATTORE , L.; D EIANA , S.; S PANO , S.M.; ET AL . Endocannabinoid system and opioid addiction: Behavioural aspects. Pharmacology, Biochemistry and Behavior 81:343–359, 2005. PMID: 15935459 F ATTORE , L.; S PANO , M.S.; D EIANA , S.; ET AL . An endocannabinoid mechanism in relapse to drug seeking: A review of animal studies and clinical per­ spectives. Brain Research Reviews 53:1–16, 2007. PMID: 16839608 F ILLIOL , D.; G HOZLAND , S.; C HLUBA , J.; ET AL . Mice deficient for delta- and mu-opioid receptors exhibit opposing alterations of emotional responses. Nature Genetics 25:195–200, 2000. PMID: 10835636 F INNEGAN , T.F.; C HEN , S.R.; AND P AN , H.L. Effect of the {mu} opioid on excitatory and inhibitory synaptic inputs to periaqueductal gray- projecting neurons in the amygdala. Journal of Pharmacology and Experimental Therapeutics 312:441–448, 2005. PMID: 15388784 F OSTER , K.L.; M C K AY , P.F.; S EYOUM , R.; ET AL . GABA(A) and opioid receptors of the central nucleus of the amygdala selectively regulate ethanol- maintained behaviors. Neuropsychopharmacology 29:269–284, 2004. PMID: 14666116 F REUND , T.F.; K ATONA , I.; AND P IOMELLI , D. Role of endogenous cannabinoids in synaptic signaling. Physiological Reviews 83:1017–1066, 2003. PMID: 12843414 G IANOULAKIS , C. Endogenous opioids and addic­ tion to alcohol and other drugs of abuse. Current Topics in Medicinal Chemistry 4:39–50, 2004. PMID: 14754375 G ONZALEZ , S.; F ERNANDEZ -R UIZ , J.; S PARPAGLIONE , V.; ET AL . Chronic exposure to morphine, cocaine or ethanol in rats produced different effects in brain cannabinoid CB(1) receptor binding and mRNA levels. Drug and Alcohol Dependence 66:77–84, 2002. PMID: 11850139 G ONZALEZ , S.; S CHMID , P.C.; F ERNANDEZ -R UIZ , J.; ET AL . Region-dependent changes in endo­ cannabinoid transmission in the brain of morphine- dependent rats. Addiction Biology 8:159–166, 2003.
Image of page 10
Image of page 11

  • Left Quote Icon

    Student Picture

  • Left Quote Icon

    Student Picture

  • Left Quote Icon

    Student Picture